HCM
ELV icon

Hudson Capital Management’s Elevance Health ELV Stock Holding History

Hudson Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-771
Closed -$218K – 75
2019
Q2 		$218K Sell
771
-226
-23% -$61.7K 0.12% 75
2019
Q1 		$286K Sell
997
-237
-19% -$68.5K 0.17% 70
2018
Q4 		$324K Sell
1,234
-238
-16% -$65.4K 0.24% 66
2018
Q3 		$403K Sell
1,472
-449
-23% -$117K 0.31% 61
2018
Q2 		$457K Sell
1,921
-546
-22% -$126K 0.32% 65
2018
Q1 		$542K Sell
2,467
-6,054
-71% -$1.42M 0.4% 59
2017
Q4 		$1.92M Buy
+8,521
New +$1.81M 1.41% 22

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return

Hudson Capital Management's ELV Position: Q3 2019 in Review

Hudson Capital Management sold out of Elevance Health (ELV) in Q3 2019, closing a stake of 771 shares — an estimated $218K sold.

Hudson Capital Management first reported a position in ELV in Q4 2017 and held it in 7 quarters. The position peaked at $1.92M in Q4 2017. 1,014 funds tracked by Wall St. Rank hold ELV as of Q3 2019.

  • Hudson Capital Management reported no remaining Elevance Health position as of Q3 2019 after selling out during the quarter.
  • Hudson Capital Management sold 771 Elevance Health shares in Q3 2019, an estimated $218K.
  • Hudson Capital Management first reported a position in Elevance Health in Q4 2017 and held it in 7 quarters.
  • Hudson Capital Management's Elevance Health position peaked at $1.92M in Q4 2017.
  • 1,014 funds tracked by Wall St. Rank held Elevance Health as of Q3 2019.

Based on Hudson Capital Management's 13F filing for Q3 2019, filed 22 Oct 2019.